These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7964492)

  • 1. Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis.
    Evans TJ; Moyes D; Carpenter A; Martin R; Loetscher H; Lesslauer W; Cohen J
    J Exp Med; 1994 Dec; 180(6):2173-9. PubMed ID: 7964492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant tumor necrosis factor-alpha p80 receptor:Fc fusion protein decreases circulating bioactive tumor necrosis factor-alpha but not lung injury or mortality during immunosuppression-related gram-negative bacteremia.
    Lechner AJ; Johanns CA; Matuschak GM
    J Crit Care; 1997 Mar; 12(1):28-38. PubMed ID: 9075062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor (TNF)-alpha-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptors.
    Frishman JI; Edwards CK; Sonnenberg MG; Kohno T; Cohen AM; Dinarello CA
    J Infect Dis; 2000 Dec; 182(6):1722-30. PubMed ID: 11069245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins.
    Scallon BJ; Trinh H; Nedelman M; Brennan FM; Feldmann M; Ghrayeb J
    Cytokine; 1995 Nov; 7(8):759-70. PubMed ID: 8664442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocytopenia reduces release of soluble TNF receptor p75 in endotoxin-stimulated mice: a possible mechanism of enhanced TNF activity.
    Steinshamn S; Bemelmans MH; Buurman WA; Waage A
    Cytokine; 1995 Jan; 7(1):50-6. PubMed ID: 7749066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75.
    Sheehan KC; Pinckard JK; Arthur CD; Dehner LP; Goeddel DV; Schreiber RD
    J Exp Med; 1995 Feb; 181(2):607-17. PubMed ID: 7836916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory response after infusion of p55 soluble tumor necrosis factor receptor fusion protein for severe sepsis.
    Butty VL; Roux-Lombard P; Garbino J; Dayer JM; Ricou B;
    Eur Cytokine Netw; 2003; 14(1):15-9. PubMed ID: 12799209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF receptor fusion proteins are effective inhibitors of TNF-mediated cytotoxicity on human KYM-1D4 rhabdomyosarcoma cells.
    Butler DM; Scallon B; Meager A; Kissonerghis M; Corcoran A; Chernajovsky Y; Feldmann M; Ghrayeb J; Brennan FM
    Cytokine; 1994 Nov; 6(6):616-23. PubMed ID: 7893970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.
    Ashkenazi A; Marsters SA; Capon DJ; Chamow SM; Figari IS; Pennica D; Goeddel DV; Palladino MA; Smith DH
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10535-9. PubMed ID: 1660140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro comparison of inhibiting ability of soluble TNF receptor p75 (TBP II) vs. soluble TNF receptor p55 (TBP I) against TNF-alpha and TNF-beta.
    Terlizzese M; Simoni P; Antonetti F
    J Interferon Cytokine Res; 1996 Dec; 16(12):1047-53. PubMed ID: 8974008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma.
    Bemelmans MH; Gouma DJ; Buurman WA
    J Immunol; 1993 Nov; 151(10):5554-62. PubMed ID: 8228246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.
    Abraham E; Glauser MP; Butler T; Garbino J; Gelmont D; Laterre PF; Kudsk K; Bruining HA; Otto C; Tobin E; Zwingelstein C; Lesslauer W; Leighton A
    JAMA; 1997 May; 277(19):1531-8. PubMed ID: 9153367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia.
    van der Poll T; Jansen J; van Leenen D; von der Möhlen M; Levi M; ten Cate H; Gallati H; ten Cate JW; van Deventer SJ
    J Infect Dis; 1993 Oct; 168(4):955-60. PubMed ID: 8397270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.
    Mohler KM; Torrance DS; Smith CA; Goodwin RG; Stremler KE; Fung VP; Madani H; Widmer MB
    J Immunol; 1993 Aug; 151(3):1548-61. PubMed ID: 8393046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble TNFR II/IgG1 Fc fusion protein treatment in the LPS-mediated septic shock of rats.
    Guo Z; Wang S; Jiao Q; Xu M; Xu Z
    Biomed Pharmacother; 2009 Aug; 63(7):537-42. PubMed ID: 18848768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling.
    Alexopoulou L; Pasparakis M; Kollias G
    Eur J Immunol; 1997 Oct; 27(10):2588-92. PubMed ID: 9368614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and cleavage of tumor necrosis factor-alpha and tumor necrosis factor receptors by human monocytic cell lines upon direct contact with stimulated T cells.
    Vey E; Burger D; Dayer JM
    Eur J Immunol; 1996 Oct; 26(10):2404-9. PubMed ID: 8898953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF receptors in murine Candida albicans infection: evidence for an important role of TNF receptor p55 in antifungal defense.
    Steinshamn S; Bemelmans MH; van Tits LJ; Bergh K; Buurman WA; Waage A
    J Immunol; 1996 Sep; 157(5):2155-9. PubMed ID: 8757341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis.
    Childs LM; Goater JJ; O'Keefe RJ; Schwarz EM
    J Bone Joint Surg Am; 2001 Dec; 83(12):1789-97. PubMed ID: 11741056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.